HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxcarbazepine and spasticity: further observations.

Abstract
The previously described anti-spastic effect of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine was found accidentally in 2 patients undergoing a double-blind comparative study for evaluation of antiepileptic effect. In this study oxcarbazepine was given orally in doses of 300-2700 mg daily to one patient with transverse myelitis and to two patients with multiple sclerosis, all of whom had clinically disabling spasticity in the form of difficulty in walking, lower limb rigidity, spastic contractions of the lower limbs and ankle clonus. Anti-spastic effect was observed at doses between 600-1200 mg daily and consisted in a substantial decrease in the above symptoms of spasticity. The anti-spastic effect appears at a dose immediately below that which produces nausea, dizziness and somnolence.
AuthorsP R Bittencourt
JournalArquivos de neuro-psiquiatria (Arq Neuropsiquiatr) Vol. 46 Issue 4 Pg. 382-4 (Dec 1988) ISSN: 0004-282X [Print] Germany
PMID3072937 (Publication Type: Case Reports, Clinical Trial, Journal Article)
Chemical References
  • Anticonvulsants
  • Carbamazepine
  • 10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide
  • Oxcarbazepine
Topics
  • Adult
  • Anticonvulsants (therapeutic use)
  • Carbamazepine (administration & dosage, analogs & derivatives, therapeutic use)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Epilepsy (drug therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Muscle Spasticity (drug therapy)
  • Oxcarbazepine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: